• Expansion of PVP production to Asia Pacific;
• Secures high-quality supply of PVP to meet growing global demands across several industries;
• Completes first step of multi-location investments into the NVP/PVP value chain.
The new plant will produce PVP K30 powder, a polymer used as a base for several applications including pharma excipients, detergents, cosmetics and technical applications. The production of the new PVP plant expands BASF’s reach to customers in Asia Pacific, especially in China, with continued reliable and high-quality supply.
“The new plant in Shanghai affirms our commitment to customers in multiple industries and marks a key milestone for the transfer of global PVP production technology to Asia Pacific,” said Michael Heinz, Member of the Board of Executive Directors, BASF SE, responsible for the company’s Performance Products segment.
PVP technology leadership introduced in Asia Pacific
In 2015, BASF announced plans for global investments into its NVP (N-vinylpyrrolidone)/PVP value chain of up to USD 70 million. The plans include the extension of capacities in Ludwigshafen, Germany and Geismar, Louisiana (USA), along with technology introduction in Shanghai, China. “We are delighted to celebrate the inauguration of the new PVP plant in Shanghai. This successfully concludes the first step of our global multi-location investment into the NVP/PVP value chain,” said Saori Dubourg, President of BASF’s Nutrition & Health division. The state-of-the-art plant is equipped with sophisticated production facilities, including a high-quality control laboratory as well as substantial warehousing capacity.
A multi-functional polymer
PVP can be used in a broad range of applications due to its varied features:
• Easily soluble in water and solvents;
• Excellent in adhesive properties; enhances solubility of active pharmaceutical ingredients (APIs);
• Non-irritating to the skin; does not pose a health hazard;
• Temperature-resistant, pH-stable, non-ionic and colorless.
The new plant operates in compliance with local and international Good Manufacturing Practice standards, for example as defined by IPEC (International Pharmaceutical Excipient Councils) and EFfCI (European Federation for Cosmetic Ingredients), applicable for the pharmaceutical and cosmetic industry. A large portion of BASF’s PVP products are marketed into the pharmaceutical industry and sold under the name Kollidon®, which complies with leading international Pharmacopeia standards, as set for example, by USP-NF and CP.
BASF is the inventor and one of the market leaders for PVP a success story for more than 75 years.
At BASF (basf.com), we create chemistry for a sustainable future. We combine economic success with environmental protection and social responsibility. The approximately 112,000 employees in the BASF Group work on contributing to the success of our customers in nearly all sectors and almost every country in the world. Our portfolio is organized into five segments: Chemicals, Performance Products, Functional Materials & Solutions, Agricultural Solutions and Oil & Gas. BASF generated sales of more than €70 billion in 2015. BASF shares are traded on the stock exchanges in Frankfurt (BAS), London (BFA) and Zurich (AN).